MIAMI, FL – February 12, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company’s CEO, S. Parikh Mars, was featured in a live interview with The Wall Street Analyzer in a wide-ranging discussion that touched on the Company’s breakout 2019 performance, its core strategic priorities, the recent 2019-nCoV (Wuhan Coronavirus) outbreak, and other themes that the Company views as key growth drivers in 2020 and beyond.Current and prospective shareholders can listen to the interview here.In the interview, Mars commented on the Company’s breakout year in 2019, noting that it was perhaps the best year in the Company’s history, adding multiple new pharmacy locations, a new building, and putting in motion a broad consolidation of resources. In addition, Mars noted that the Company branched out in 2019 with new initiatives and new accomplishments, including data analytics, key growth drivers, new operational standards, telemedicine, and its goal to be an innovator in a space that's ripe for disruption.The interview notes that the Company closed 2019 with near $10 million sales quarters and ended the year with over $32M in sales, driven by both organic and M&A related factors that boosted both top and bottom line results. Mars noted that the Company posted record-breaking results in prescriptions, revenues, and showed year-over-year improvement in just about every metric in 2019.Looking ahead, Mars noted, "One of the things we feel we do better than anybody else is we understand the patient. And we really model ourselves after a healthcare company, and not so much a pharmacy. While we do provide a lot of pharmacy services, our healthcare services are starting to come to the forefront as we provide consultation and medication therapy management, data analytics for usage, formulary compliance, doing remote health monitoring. All these other things that seem to be unique to patients today, where many patients are seeing their doctor only once or twice a year, and most of their healthcare happens at home. So we've become experts in that space, and believe that that's the trend going forward. And we're looking at developing our own software to be able to automate factors that will allow us to have better patient engagement, more personal patient engagement."The interview further touched on some of the Company’s core strategic objectives, including CBD products, telemedicine, recent management improvements, board additions, a coming uplist onto a major US exchange, and the Company’s move toward overall profitability in 2020.For more information about Progressive Care, please visit the company’s website.Connect and stay in touch with us on social media: Progressive Care Inc.https://www.facebook.com/ProgressiveCareUS/https://twitter.com/ProgressCareUS PharmCo, LLChttps://www.facebook.com/pharmcorx/https://twitter.com/PharmCoRx Five Star RXhttps://www.fivestarrx.com/https://www.facebook.com/fivestarrx/ About Progressive Care Inc.Progressive Care Inc. (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. Cautionary Statement Regarding Forward-Looking StatementsStatements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance, and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements. Investor Relations Contact:Armen Karapetyan, Progressive CareSenior Advisor Business DevelopmentArmen@progressivecareus.comwww.progressivecareus.comwww.pharmcopharmacy.com Public Relations Contact:Caitlin Franscell, CMW Mediacaitlin@cmwmedia.comwww.cmwmedia.com
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!